Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups

Pediatric Blood and Cancer

Volumn 50, Issue 6, 2008, Pages 1130-1134

  Van Den Heuvel Eibrink, Marry M ^a,b   Grundy, Paul ^c   Graf, Norbert ^d   Pritchard Jones, Kathy ^e   Bergeron, Christophe ^f   Patte, Catherine ^a   Van Tinteren, Harm ^g   Rey, Annie ^h   Langford, Carolyn ⁱ   Anderson, Jim R ^j   De Kraker, Jan ^k  

^a Department of Pediatric Oncology/Hematology ^*  (France)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY OF ALBERTA   (Canada)

^d SAARLAND UNIVERSITY   (Germany)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f CENTRE LÉON BÉRARD   (France)

^g Integraal Kankercentrum Amsterdam   (Netherlands)

^h Datacenter   (France)

ⁱ UNIVERSITY OF LEICESTER   (United Kingdom)

^j UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^k EMMA CHILDREN S HOSPITAL   (Netherlands)

more..

Author keywords

Infants; Mesoblastic nephroma; Nephroblastoma; Renal tumors; Rhabdoid tumor of kidney

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CLEAR CELL SARCOMA; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; INFANT; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MESOBLASTIC NEPHROMA; METASTASIS; NEPHRECTOMY; NEPHROBLASTOMA; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; RHABDOID TUMOR; SURGICAL APPROACH; SURVIVAL RATE;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY NEOPLASMS; MALE; SURVIVAL RATE; WILMS TUMOR;

EID: 42349114114     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21389     Document Type: Article

References (22)

1. Glick RD, Hicks MJ, Nuchtern JG, et al. Renal tumors in infants less than 6 months of age. J Pediatr Surg 2004;39:522-525.
2. Skotnicka-Klonowicz G, Baglaj M, Sawicz-Birkowska K, et al. Nephroblastoma in children aged less than 6 months at diagnosis. Med Wieku Rozwoj 2003;7:347-757.
3. Corn BW, Goldwein JW, Evans I. et al. Outcomes in low-risk babies treated with half-dose chemotherapy according to the Third National Wilms' Tumor Study. J Clin Oncol 1992;10:1305-1309.
4. Kullendorff CM, Wiebe T. Wilms' tumor in infancy. Acta Paediatr 1998;87:747-750.
5. Pritchard-Jones K, Kelsey A, Vujanic G, et al. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: A study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group. J Clin Oncol 2003;21:3269-3275;
6. Ritchey ML, Azizkhan RG, Beckwith JB, et al. Neonatal Wilms tumor. J Pediatr Surg 1995;30:856-859.
7. Green DM, Breslow NE, Beckwith JB, et al. Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: A report from the National Wilms' Tumor Study. J Clin Oncol 1993;11:91-95.
8. Morgan E, Baum E, Breslow N, et al. Chemotherapy-related toxicity in infants treated according to the Second National Wilms' Tumor Study. J Clin Oncol 1988;6:51-55.
9. Hrabovsky EE, Othersen HB, Jr., deLorimier A, et al. Wilms' tumor in the neonate: A report from the National Wilms' Tumor Study. J Pediatr Surg 1986;21:385-387.
10. Tournade MF, Com-Nougue C, de Kraker J, et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: Results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 2001;19:488-500.
11. de Kraker J, Graf N, van Tinteren H, et al. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumor (SIO Ptrial): A randomised controlled trial. Lancet; 2004;364:1229-1235.
12. Neville HL, Ritchey ML. WILMS' tumor, overview of national Wilms' Tumor Study Group Results. Ped Urol Oncol 2003;27:435-442.
13. Mitchell C, Jones KP, Shannon R, et al. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumor: Results of a randomised trial (UKW3) by the UK Children's Cancer Study Group. Eur J Cancer 2006;42:2554-2562.
14. Seibel NL, Li S, Breslow NE, et al. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: A report from the National Wilms' Tumor Study Group. J Clin Oncol 2004;22:468-473.
15. Seibel N, Sun J, Anderson JR, et al. Outcome of clear cell sarcoma of the kidney (CCSK) treated on the National Wilms Tumor Study - 5 (NWTS). 24,502.2006.Ref Type. Conf. Proc. Ref ID 2006; 6076.
16. Green DM, Breslow NE, Beckwith JB, et al. Treatment of children with clear-cell sarcoma of the kidney: A report from the National Wilms' Tumor Study Group. J Clin Oncol 1994;12:2132-2137.
17. Hung NA. Congenital "clear cell sarcoma of the kidney". Virchows Arch 2005;446:566-568.
18. Vujanic GM, Sandstedt B, Harms D, et al. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol 2002;38:79-82.
19. Dorey FJ, Korn EL. Effective sample sizes for confidence intervals for survival probabilities. Stat Med 1987;6:679-687.
20. Graf N, Tournade MF, de Kraker J. The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology. Urol Clin North Am 2000;27:443-454.
21. Isaacs H, Jr. Congenital and neonatal malignant tumors. A 28-year experience at Children's Hospital of Los Angeles. Am J Pediatr Hematol Oncol 1987;9:121-129.
22. Lowe LH, Isuani BH, Heller RM, et al. Pediatric renal masses: Wilms tumor and beyond. Radiographics 2000;20:1585-1603.